adMare BioInnovations (adMare) is proud to be one of the two applicant level partners of the Health Challenges in Chronic Inflammation Phase 2 organized by the Canadian Institutes of Health Research (CIHR).
By partnering with CIHR on the Team Grant: Preparation to Trial: Inflammation for Chronic Conditions grant, we want to partner with researchers in a collaborative program to advance technologies, develop therapeutics, and build companies.
The opportunity to partner on this translationally-focused grant is a benefit both for adMare in allowing us to identify early-stage opportunities of high therapeutic potential, and for the academic investigator in gaining a preclinical drug development partner to rapidly advance their technology towards commercialization.
The CIHR will be hosting the following webinar to share with participants the requirements of the funding opportunity “Team Grant : Preparation to Trial: Inflammation for Chronic Conditions” and to answer questions on how to apply.
Stuart Cain, Associate Director, Scientific Evaluation at adMare will take part in the Information Session on November 10 at 1 pm EST to provide further details on this collaboration opportunity.
If you are interested, join the webinar through the link.